What is he best known for?
The fields of study he is best known for:
- Internal medicine
- Diabetes mellitus
- Endocrinology
His primary areas of study are Internal medicine, Endocrinology, Diabetes mellitus, Insulin and Type 2 diabetes.
In his work, Exenatide and Randomized controlled trial is strongly intertwined with Liraglutide, which is a subfield of Internal medicine.
His works in Glucagon-like peptide-1, Glucagon, Incretin, Postprandial and Insulin resistance are all subjects of inquiry into Endocrinology.
He has included themes like Gastrointestinal hormone and Glucagon secretion in his Glucagon-like peptide-1 study.
His work carried out in the field of Diabetes mellitus brings together such families of science as Gastroenterology and Carbohydrate metabolism.
He combines subjects such as Basal, Glucose tolerance test, Glucose clamp technique and Skeletal muscle with his study of Type 2 diabetes.
His most cited work include:
- Effect of 6-week course of glucagon-like peptide 1 on glycaemic control, insulin sensitivity, and β-cell function in type 2 diabetes: a parallel-group study (1213 citations)
- Reduced Postprandial Concentrations of Intact Biologically Active Glucagon-Like Peptide 1 in Type 2 Diabetic Patients (792 citations)
- Determinants of the impaired secretion of glucagon-like peptide-1 in type 2 diabetic patients. (739 citations)
What are the main themes of his work throughout his whole career to date?
Sten Madsbad focuses on Internal medicine, Endocrinology, Insulin, Diabetes mellitus and Type 2 diabetes.
While the research belongs to areas of Internal medicine, he spends his time largely on the problem of Glucagon-like peptide-1, intersecting his research to questions surrounding Gastric emptying.
Incretin, Pancreatic hormone, C-peptide, Carbohydrate metabolism and Liraglutide are among the areas of Endocrinology where the researcher is concentrating his efforts.
His study in Insulin is interdisciplinary in nature, drawing from both Hormone and Type 1 diabetes.
His work in Diabetes mellitus addresses subjects such as Gastric bypass surgery, which are connected to disciplines such as Roux-en-Y anastomosis.
His Type 2 diabetes research includes elements of Metformin, Body mass index, Surgery, Gastroenterology and Type 2 Diabetes Mellitus.
He most often published in these fields:
- Internal medicine (94.06%)
- Endocrinology (77.53%)
- Insulin (47.51%)
What were the highlights of his more recent work (between 2017-2021)?
- Internal medicine (94.06%)
- Endocrinology (77.53%)
- Diabetes mellitus (42.22%)
In recent papers he was focusing on the following fields of study:
His primary scientific interests are in Internal medicine, Endocrinology, Diabetes mellitus, Type 2 diabetes and Insulin.
His research in Internal medicine intersects with topics in Gastroenterology and Liraglutide.
His work on Hormone, Carbohydrate metabolism and Glucagon-like peptide-1 as part of general Endocrinology study is frequently linked to Peptide YY, therefore connecting diverse disciplines of science.
His Diabetes mellitus research incorporates themes from Relative risk, Confidence interval and Gastric bypass surgery.
In Type 2 diabetes, Sten Madsbad works on issues like Metformin, which are connected to Adverse effect.
His Insulin study which covers Type 1 diabetes that intersects with Bolus.
Between 2017 and 2021, his most popular works were:
- Mechanisms in bariatric surgery: Gut hormones, diabetes resolution, and weight loss. (60 citations)
- Efficacy and safety of oral semaglutide in patients with type 2 diabetes and moderate renal impairment (PIONEER 5) : a placebo-controlled, randomised, phase 3a trial (58 citations)
- Postprandial Nutrient Handling and Gastrointestinal Hormone Secretion After Roux-en-Y Gastric Bypass vs Sleeve Gastrectomy. (47 citations)
In his most recent research, the most cited papers focused on:
- Internal medicine
- Diabetes mellitus
- Type 2 diabetes
His scientific interests lie mostly in Internal medicine, Endocrinology, Type 2 diabetes, Postprandial and Diabetes mellitus.
His research integrates issues of Gastroenterology and Liraglutide in his study of Internal medicine.
His study in the field of Glucagon, Insulin resistance, Small intestine and NEFA is also linked to topics like Context.
His work deals with themes such as Glucagon-like peptide-1, Appetite and Weight loss, which intersect with Postprandial.
In his papers, Sten Madsbad integrates diverse fields, such as Diabetes mellitus and Crossover study.
His Insulin research integrates issues from Type 1 diabetes and Carbohydrate.
This overview was generated by a machine learning system which analysed the scientist’s
body of work. If you have any feedback, you can
contact us
here.
